Leaderboard

En | De
Sie sind hier: Onkologie 05. Dezember 2025
Suchen
medline.ch
Onkologie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 94583  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 1891657  
   
Unveiling the power of PARP inhibitors: a meta-analysis on newly diagnosed advanced ovarian cancer maintenance therapy.
Expert Rev Anticancer Ther
Zhang W, Zhang N, Li S, Ge W, Qiu H, Wu Q.
PMID: 41347401 [PubMed - as supplied by publisher]


Multi-parametric magnetic resonance imaging-based radiomics for differentiation of skull base osteomyelitis from locally advanced nasopharyngeal carcinoma: a multi-center external validation study.
Diagn Interv Radiol
Atak F, Avc, Pekçevik Y, Karaosmano.
PMID: 41347386 [PubMed - as supplied by publisher]


Adverse reactions of PD-1/PD-L1 inhibitors in cancer: FEARS database analysis and protocols to mitigate immune-related events in elderly patients and when using pembrolizumab and atezolizumab.
Int J Clin Pharmacol Ther
He S, Chen J, Gu L, Zeng W, Li T, Zhao W.
PMID: 41347380 [PubMed - as supplied by publisher]


Mitoxantrone-engineered multifunctional nanoplatforms for precision imaging-guided synergistic cancer therapy: recent advances and future perspectives.
J Mater Chem B
Yu J, Qiu Z, Yan S, Lin A, Li Y.
PMID: 41347370 [PubMed - as supplied by publisher]


Renoprotective properties of resveratrol in the treatment of renal fibrosis, renal cell carcinoma, diabetic nephropathy and nephrotoxicity: a review of current evidence based on underlying cellular mechanisms.
Toxicol Mech Methods
AlRamadneh TN, Abdulsahib WK, Ismael SH, Roopashree R, Mohanty B, Nandhini SU, Arora V, Chauhan AS, Farhood B.
PMID: 41347316 [PubMed - as supplied by publisher]


Treatment options for senior gastric cancer patients (aged ≥60 years): a worldwide network meta-analysis.
Int J Surg
Cheng J, Cai M, Wang G.
PMID: 41347279 [PubMed - as supplied by publisher]


Letter to editor about Ultra-short-period perioperative pulmonary rehabilitation on short-term outcomes after surgery in smoking patients with lung cancer: a randomized clinical trial.
Int J Surg
Cao ZG.
PMID: 41347274 [PubMed - as supplied by publisher]


Efficacy and safety of TACE plus lenvatinib with PD-1 inhibitor for unresectable huge hepatocellular carcinoma: a multicenter retrospective cohort study.
Int J Surg
Liang Y, Yang J, Li H, Wu J, Tan W, Ren Y, Li X, Li R, Wang X, Liu M, Zhou Q, Duan F.
PMID: 41347264 [PubMed - as supplied by publisher]


Development and validation of a post-chemoradiotherapy prognostic model in patients with locally advanced rectal cancer who underwent radical surgery after neoadjuvant chemoradiotherapy: a retrospective, multicenter, cohort study.
Int J Surg
Chen Y, Zheng J, Ba YC, Miao HS, Zhao Y, Sun DY, Zhang Y, Ning PF, Li XY, Tang XY, Lang JX, Liu YL, Chi ZC, Zhu J, Zhang CD, Zhang R.
PMID: 41347259 [PubMed - as supplied by publisher]


Oral health-related quality of life in head and neck cancer: a systematic review.
Front Oral Health
Piyarathne N, Sinclair S, Elsayed KS, Cook C, Gupta E, Abu-Eid R.
PMID: 41347226 [PubMed]


Therapeutic Applications and Target Strategies of Antibody-Drug Conjugates in Ovarian Cancer.
Iran J Pharm Res
Liu Q, Zhou R, He T, Zhao Y, Yang M.
PMID: 41347223 [PubMed]


Prognostic Significance of Preoperative Inflammatory Markers in Thyroid Follicular Neoplasms: Focus on Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios.
J Clin Pract Res
Jafari MM, Rasihashemi SZ, Farashi E.
PMID: 41347201 [PubMed]


Metabolomics Analysis-Based Machine Learning for Endometrial Cancer Diagnosis: Integration of Biomarker Discovery and Explainable Artificial Intelligence.
J Clin Pract Res
Yagin FH, Pinar A.
PMID: 41347192 [PubMed]


Metformin for primary prevention of colorectal neoplasms in adenoma-free populations: a systematic review and dose-response meta-analysis.
Front Pharmacol
Shen M, Lu S, Xu Z, Zhou F, Sheng LT, Yu Q.
PMID: 41347173 [PubMed]


Chinese herbal injections combined with EGFR-TKIs for intervention of non-small cell lung cancer: a systematic review and meta-analysis.
Front Pharmacol
Yuan Z, Yan M, Wu T, Zhang G, Yang G, Wang X.
PMID: 41347160 [PubMed]


Targeting emerging amino acid dependencies and transporters in cancer therapy.
Front Pharmacol
Akinlalu A, Ogberefor E, Gao T, Sun D.
PMID: 41347155 [PubMed]


Artemisinin and its derivatives: all-rounders that may prevent the progression from lung injury to lung cancer.
Front Pharmacol
Xie X, Chen Q, Guo C, Zeng J, He Q.
PMID: 41347152 [PubMed]


G protein-coupled receptors in prostate cancer: research progress and therapeutic targets.
Front Cell Dev Biol
Xiong W, Zhou B, Shi J, Ni D, Xiong Z.
PMID: 41347146 [PubMed]


Risk factors and early prediction of pancreatic cancer among patients with diabetes mellitus: a systematic review and meta-analysis.
Front Endocrinol (Lausanne)
Cong H, Song J, Liu L, Liu S, Wu H, Nan Z.
PMID: 41347135 [PubMed - indexed for MEDLINE]


Prognostic factors for overall survival in patients with metastatic castration-resistant prostate cancer treated with radium-223: a meta-analysis of real-world evidence.
Front Oncol
Song B, Shao H, He Y, Zhu X, Qin P.
PMID: 41347095 [PubMed]


   
   Artikel 1 - 20 / 1891657    Seite 1 von 94583  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1